Sign Up for Updates

Mobile App

In Season The allergy e-zine from OMNARIS

Nasal Allergy 360

I'll do anything to get relief from nasal allergy symptoms! Sound familiar? Well, there are a number of different steps you can take to help relieve symptoms. But to get the best relief, it's best to take a 360ยบ approach to combating nasal allergies — using more than one way to fight the problem.

Reduce Allergens + Reduce Irritants + OMNARIS Nasal Spray
To help minimize nasal allergy symptoms as much as possible:

  • Minimize your exposure to allergens that can cause symptoms (such as pollen, pet dander, dust, or mold) by taking steps to allergy-proof your home
  • Limit your exposure to substances that irritate your sensitive airways (like cigarette smoke and harsh cleaning products)
  • Choose environmentally-friendly cleaning products
  • Ask your healthcare professional if OMNARIS Nasal Spray could help keep your symptoms under control

Any one of these steps alone may help reduce your symptoms. But taking several different steps together may offer you more complete relief from nasal allergies. Relief can indeed be here!

Previous Article

NEXT: Spring Allergens: They're in the Air

Small Font
Medium Font
Large Font

email

print

Newsletter Archive

Stay in the Know!

Get the latest info about nasal allergies and OMNARIS, plus get great money-saving offers.

Sign up now

OMNARIS (ciclesonide) Nasal Spray is for the treatment of nasal allergy symptoms associated with seasonal allergic rhinitis (seasonal allergies) in adults and children 6 years of age and older, and with perennial allergic rhinitis (year-round allergies) in adults and adolescents 12 and older.

Important Safety Information

Patients using corticosteroid drugs that weaken the immune system are more susceptible to infection and should avoid exposure to chickenpox or measles. If you have tuberculosis, eye herpes, or untreated infections of any kind, speak to your doctor before using OMNARIS. Yeast infections of the nose and throat may occur.

Patients who have recently had an ulcer in the nose, trauma to the nose or nasal surgery should not use OMNARIS until healing has occurred. Rare instances of nasal irritation and eye problems have been reported following the use of nasal steroids. Talk with your doctor if you have a history of eye problems or experience a change in vision.

Patients taking higher doses of a nasal steroid than recommended, or certain other at-risk individuals, may experience symptoms of a hormonal imbalance, including very rarely changes in menstruation, acne, and weight gain. Like all steroid nasal sprays, OMNARIS may cause slowed growth in children. The growth of children using OMNARIS should be monitored routinely by a healthcare professional.

The most common side effects that may occur with OMNARIS are headache, nosebleed, sore throat and ear pain.

The health information contained on this website is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. The product discussed on this site may have different product labeling in different countries. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.

For more information, please see the OMNARIS Full Prescribing Information and the OMNARIS Patient's Instructions for Use.

OMNARIS is available by prescription. Ask your healthcare professional if OMNARIS is right for you. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The health information contained on this website is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. This site is intended for U.S. residents only. The product discussed on this site may have different product labeling in different countries. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.

© 2011 Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Dainippon Sumitomo Pharma Co. Ltd., and is a registered trademark of Dainippon Sumitomo Pharma Co. Ltd.
OMNARIS is a registered trademark of Nycomed GmbH, used with permission.